Archives: Speakers

Michael Hickey is the VP of Clinical Operations at Bio-Path Holdings, LLC, a small biotech focused on developing liposomal antisense oligonucleotides in leukemia, lymphoma and solid tumors.  With over 26 years of experience at large and small sponsors including 6 years on the CRO side, Michael brings a truly collaborative approach and broad expertise in oncology and rare disease clinical drug development.  His clinical experience has focused on challenging indications such as head-and-neck cancer, colorectal cancer, breast cancer with BRCA mutations as well as chemotherapy induced myelosuppression, hemophilia, and Battens Disease.

As a scientist, researcher, and educator for more than 25 years, Ingrid looks at healthcare from a holistic perspective — ensuring a patient-driven focus is combined with data-driven science. Using digital data to promote precision medicine, Ingrid focuses on increasing the pace of medical discoveries and ultimately bringing therapies to patients faster, as well as delivering solutions to people when they want them and where they want them. As Senior Vice-President of Research and Strategy for Medable Inc., Ingrid uses strong technical, analytic and genetics background to improve the clinical trial experience for patients. The focus is on modernizing clinical trials, the digital virtual healthcare space, and creating technology and tools to collect precision data so we can get solutions to patients in half the time.

Andrea Patton, PhD is a Senior Behavioural Epidemiologist who leads the prevalence research team within the Centre for Substance Use Research Ltd (CSUR), Glasgow, United Kingdom. Andrea has over 15 years of experience working in public health in the United Kingdom for academia, regulatory bodies and industry.